FAMICORD AG (V3V.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:V3V - DE000A0BL849 - Common Stock
6 EUR
-0.15 (-2.44%)
We assign a fundamental rating of 3 out of 10 to V3V. V3V was compared to 33 industry peers in the Health Care Providers & Services industry. V3V has a bad profitability rating. Also its financial health evaluation is rather negative. V3V is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
V3V had positive earnings in the past year.
V3V had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: V3V reported negative net income in multiple years.
Of the past 5 years V3V 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.61%, V3V is doing worse than 63.64% of the companies in the same industry.
V3V has a Return On Equity (10.63%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROIC | N/A |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
V3V's Profit Margin of 3.20% is in line compared to the rest of the industry. V3V outperforms 57.58% of its industry peers.
V3V has a Gross Margin of 36.66%. This is in the better half of the industry: V3V outperforms 63.64% of its industry peers.
V3V's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
2. Health
2.1 Basic Checks
V3V does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, V3V has more shares outstanding
V3V has more shares outstanding than it did 5 years ago.
V3V has a better debt/assets ratio than last year.
2.2 Solvency
V3V has an Altman-Z score of 0.60. This is a bad value and indicates that V3V is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of V3V (0.60) is worse than 84.85% of its industry peers.
The Debt to FCF ratio of V3V is 2.09, which is a good value as it means it would take V3V, 2.09 years of fcf income to pay off all of its debts.
V3V's Debt to FCF ratio of 2.09 is amongst the best of the industry. V3V outperforms 96.97% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that V3V is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.56, V3V belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Altman-Z | 0.6 |
ROIC/WACCN/A
WACC6.42%
2.3 Liquidity
A Current Ratio of 0.76 indicates that V3V may have some problems paying its short term obligations.
V3V has a Current ratio of 0.76. This is in the lower half of the industry: V3V underperforms 72.73% of its industry peers.
A Quick Ratio of 0.70 indicates that V3V may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, V3V is doing worse than 60.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 109.51% over the past year.
The Revenue has been growing slightly by 7.73% in the past year.
The Revenue has been growing by 30.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
3.2 Future
The Earnings Per Share is expected to grow by 30.68% on average over the next years. This is a very strong growth
V3V is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.88% yearly.
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 42.86 indicates a quite expensive valuation of V3V.
Based on the Price/Earnings ratio, V3V is valued a bit more expensive than 75.76% of the companies in the same industry.
V3V is valuated expensively when we compare the Price/Earnings ratio to 26.39, which is the current average of the S&P500 Index.
V3V is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.86 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, V3V is valued a bit more expensive than 75.76% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of V3V indicates a somewhat cheap valuation: V3V is cheaper than 63.64% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.79 | ||
| EV/EBITDA | 12.62 |
4.3 Compensation for Growth
V3V's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as V3V's earnings are expected to grow with 34.20% in the coming years.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y34.2%
5. Dividend
5.1 Amount
No dividends for V3V!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:V3V (12/19/2025, 7:00:00 PM)
6
-0.15 (-2.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.87%
Inst Owner ChangeN/A
Ins Owners58.45%
Ins Owner ChangeN/A
Market Cap105.84M
Revenue(TTM)80.64M
Net Income(TTM)2.58M
Analysts45.71
Price Target7.65 (27.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.86 | ||
| Fwd PE | N/A | ||
| P/S | 1.31 | ||
| P/FCF | 11.79 | ||
| P/OCF | 8.74 | ||
| P/B | 4.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.62 |
EPS(TTM)0.14
EY2.33%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.51
FCFY8.48%
OCF(TTM)0.69
OCFY11.44%
SpS4.57
BVpS1.38
TBVpS-1.68
PEG (NY)0.73
PEG (5Y)N/A
Graham Number2.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 10.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.2% | ||
| GM | 36.66% | ||
| FCFM | 11.13% |
ROA(3y)-7.04%
ROA(5y)-3.48%
ROE(3y)-60.2%
ROE(5y)-34.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.67%
GM growth 5Y-8.9%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.09 | ||
| Debt/EBITDA | 1.65 | ||
| Cap/Depr | 35.61% | ||
| Cap/Sales | 3.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 147.25% | ||
| Profit Quality | 347.6% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 0.6 |
F-Score7
WACC6.42%
ROIC/WACCN/A
Cap/Depr(3y)60.39%
Cap/Depr(5y)47.49%
Cap/Sales(3y)7.53%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y34.2%
EPS Next 5Y30.68%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y57.65%
Revenue growth 5Y30.44%
Sales Q2Q%8.91%
Revenue Next Year9.33%
Revenue Next 2Y8.01%
Revenue Next 3Y7.82%
Revenue Next 5Y2.88%
EBIT growth 1Y97.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year562.86%
EBIT Next 3Y110.83%
EBIT Next 5Y79.58%
FCF growth 1Y198.46%
FCF growth 3Y20.6%
FCF growth 5Y6%
OCF growth 1Y520.19%
OCF growth 3Y37.37%
OCF growth 5Y14.78%
FAMICORD AG / V3V.DE FAQ
What is the ChartMill fundamental rating of FAMICORD AG (V3V.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to V3V.DE.
What is the valuation status for V3V stock?
ChartMill assigns a valuation rating of 3 / 10 to FAMICORD AG (V3V.DE). This can be considered as Overvalued.
What is the profitability of V3V stock?
FAMICORD AG (V3V.DE) has a profitability rating of 3 / 10.
What is the financial health of FAMICORD AG (V3V.DE) stock?
The financial health rating of FAMICORD AG (V3V.DE) is 3 / 10.